The neurobiology and generation of induced pluripotent stem (iPS) cell lines for the study of Autism Spectrum Disorder (ASD)
June 14, 2017
John Jay Gargus, MD, PhD
Institute for Clinical & Translation Science (ICTS), University of California, Irvine, Hewitt Hall, 843 Health Sciences Road, Irvine, CA 92697
The purpose of this research study is to investigate the causes of autism by evaluating individuals with autism spectrum disorder (ASD) and their families through comprehensive diagnostic and cognitive assessments. Testing includes: ADOS tests, WASI/Mullen IQ testing, blood laboratory assessments, urinalysis, saliva & breath analysis, sleep analysis, EEG and a skin biopsy for genetic analysis.
You may be eligible for participation in this study if you: have a diagnosis of autism (and are 2-65 years old); have a child or sibling with a diagnosis of autism; have a non-autistic child who is healthy (and is 7-17 years old); and you are English speaking.
This study includes approximately one-two (1-2) visits that take about 12 hours to complete. The study visit can typically be completed in one (1) visit but can be completed in two (2) visits, if requested.
You will not directly benefit from participation in this study. This study is not designed to treat any illness or to improve your health. However, this study will help researchers learn more about the causes of autism, and it is hoped that this information will help in the treatment of future patients with these conditions.
Up to $160 in compensation will be provided for completed tests.
Samantha Reiter or Rachel Nguyen, Center for Autism Research & Translation (CART)